logo
Demonising palm oil won't improve public health. Better focus on food literacy, balanced diet

Demonising palm oil won't improve public health. Better focus on food literacy, balanced diet

The Print22-05-2025

By positioning palm oil as the primary culprit behind India's growing obesity rate and LDL, or 'bad', cholesterol levels, the article misses a much larger, more nuanced picture that involves food security, farmer welfare, strategic self-sufficiency, and environmental realities. The problem of obesity in India is real and rising. But attributing it largely to palm oil consumption is misguided. India's annual per capita edible oil consumption stands at 19.7 kg, which is well above the ICMR-recommended 12 kg.
However, Minister of State for Health and Family Welfare Prataprao Jadhav recently stated in Parliament that there is ' no unanimous scientific evidence ' linking palm oil consumption to negative health effects. He also noted that the Indian Council of Medical Research – National Institute of Nutrition recommends the use of a variety of vegetable oils, including palm oil, as relying entirely on a single vegetable oil may not provide the optimal balance of fatty acids.
A recent opinion article in ThePrint , titled Oil is making India obese and import-hungry. Modi wants to change that , goes beyond merely criticising palm oil for increasing obesity in the country. It goes so far as to suggest that the Government of India should exclude this versatile vegetable oil from its National Mission on Edible Oils, citing its widespread use in the unorganised sector, which drives higher consumption and adversely affects public health.
However, this increase isn't unique to palm oil. It reflects a larger shift in dietary habits driven by urbanisation, sedentary lifestyles, and the growing intake of ultra-processed foods (UPFs). According to a 2023 WHO report, India's UPF market surged from $900 million in 2006 to nearly $38 billion in 2019. These foods, rich in refined sugars, sodium, and preservatives, pose far greater health risks than any single cooking medium.
Beyond diets
It is true that palm oil contains saturated fats, but not all saturated fats are created equal. When consumed as part of a balanced diet, palm oil is no more harmful than other edible oils. It contains nearly equal proportions of saturated and unsaturated fats and is rich in antioxidants like vitamin E. Its health impact depends more on the quantity and context of consumption than on its mere presence in the kitchen.
However, the conversation must go beyond kitchens and diets. India imports over 15 million tonnes of edible oil annually, including Rs 40,000 crore worth of palm oil, which accounts for about 56 per cent of the total imports. This heavy reliance on imports strains our foreign exchange reserves and exposes us to global price volatility and supply chain disruptions. The National Mission on Edible Oils – Oil Palm (NMEO-OP), backed by Rs 11,040 crore in funding, is a strategic effort to cut edible oils import dependency, boost domestic production, and enhance farmer incomes.
This mission is already bearing fruit. In Telangana, farmers have seen up to a 50 per cent rise in prices, earning Rs 21,000 for a tonne of Fresh Fruit Bunch (FFB) produce. States like Karnataka, Mizoram, and Arunachal Pradesh have also embraced oil palm cultivation. Importantly, in India, forest lands are not being recommended and used for oil palm cultivation, contrary to common misconceptions. Only the cultivable land of the individual farmer is under oil palm cultivation mainly as replacement of rice cultivation and that too in agro-ecologically suitable regions only. Oil palm is a rapidly expanding profitable crop in northeastern states under NMEO-OP, contrary to common misconceptions.
Also read: Palm oil cultivation is key for Atmanirbhar Bharat. It empowers farmers too
Embracing palm oil
From an environmental standpoint, palm oil is the world's most land-efficient oil crop, yielding 4-5 tonnes of oil per hectare compared to just 0.4-0.5 tonnes for soybean. According to Our World in Data, palm oil makes up 36 per cent of the world's vegetable oil production using only 9 per cent of the land devoted to oil crops. Replacing it with alternatives like soybean, rapeseed, or sunflower would demand significantly more land, potentially exacerbating deforestation. Oil palm also requires less water than resource-intensive crops like sugarcane or rice, a critical factor for water-stressed regions.
NMEO-OP also incorporates sustainability safeguards. Special provision for intercropping of annual crops in oil palm plantation has been made for the initial four years of non-bearing period of oil palm. Such agri-horticultural systems conserve land resources and are better adapted to climate change. Palm plantation provides farmer buy-back guarantees, and offers viability gap funding to protect growers from price fluctuations. The mission further encourages bilateral cooperation with countries like Malaysia in the field of palm oil, especially in research and development, seed supply, and partnership management.
Atmanirbhar Bharat is more than just a slogan; it is a strategic push for independence in critical sectors, including food and edible oils. Palm oil isn't just another cooking medium; it's a vital component of India's pursuit of edible oil security. Public health must be addressed through stronger food literacy, better regulation of UPFs, and promotion of balanced diets, not by demonising a crop that sustains thousands of farmers and reduces our import bill by billions.
Blaming palm oil unfairly may make for a dramatic headline, but India's food strategy must rise above fear-driven narratives. What the country needs is not a retreat from palm oil, but a smart, sustainable, and informed embrace of it.
The author is former Additional Commissioner (Oilseeds), Department of Agriculture & Farmers Welfare, Government of India. Views are personal.
(Edited by Aamaan Alam Khan)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aakaar Medical Technologies IPO: Check issue size, price band and other details
Aakaar Medical Technologies IPO: Check issue size, price band and other details

Economic Times

time40 minutes ago

  • Economic Times

Aakaar Medical Technologies IPO: Check issue size, price band and other details

The initial public offering (IPO) of aesthetic healthcare product maker Aakaar Medical Technologies Limited opens for subscription today, June 20, and will close on June 24, 2025. The company is looking to raise Rs 27 crore through a fresh issue of 37.5 lakh equity shares, with the shares set to list on NSE SME on June 27, subject to allotment finalisation on June 25. ADVERTISEMENT The price band for the IPO is Rs 68 to Rs 72 per share, and investors can bid for a minimum lot size of 1,600 shares. Ahead of the IPO, the company has raised Rs 7.68 crore from anchor investors by allocating 10.67 lakh shares on June 19. The issue has been structured with 47.42% reserved for qualified institutional buyers (QIBs), 14.29% for non-institutional investors (NIIs), and 33.26% for retail investors. Indorient Financial Services is acting as the book-running lead manager, while Bigshare Services is the registrar to the issue. Alacrity Securities is the designated market in 2013, Aakaar Medical Technologies operates in the medical aesthetics space, supplying dermatology and cosmetic products to physicians, surgeons, and cosmetologists. Its product mix includes skin care, hair care, injectables, laser and aesthetic devices, and home-use products, including solutions for hair loss and company distributes both domestically manufactured and imported products from countries like South Korea, Spain, Italy, and Austria, with a presence in over 15 Indian states. It has a dedicated team of 90 sales and service professionals. Financially, Aakaar reported a 33% increase in revenue to Rs 61.76 crore and 110% jump in net profit to Rs 6.04 crore in FY25. The IPO proceeds will be used primarily to meet working capital requirements and for general corporate purposes. (You can now subscribe to our ETMarkets WhatsApp channel)

India's Covid-19 cases decline even as new Omicron sub-variants emerge
India's Covid-19 cases decline even as new Omicron sub-variants emerge

Mint

timean hour ago

  • Mint

India's Covid-19 cases decline even as new Omicron sub-variants emerge

New Delhi: India's active Covid-19 caseload fell to 5,976 on Friday, down from 6,483 cases a day earlier, even as new Omicron sub-variants continue to drive infections. The country reported three deaths in the past 24 hours—two from Delhi and one from Kerala—taking the total fatalities this year to 116, according to data from the Union Health Ministry. Health authorities have identified two new Omicron sub-lineages, NB.1.8.1 and LF.7—both mutations of the JN.1 variant—as the cause of the current surge. However, scientists at the Indian Council of Medical Research (ICMR) have indicated that these new strains are not causing increased disease severity compared to earlier Omicron waves. Several states are witnessing a decline in daily infections. Kerala reported 1,309 active cases, followed by Gujarat (1,046), West Bengal (747), Delhi (632), Karnataka (466), and Maharashtra (443). According to ICMR, genome sequencing data shows that while the earlier spike was largely due to the JN.1.16 sub-variant, most recent cases are being attributed to recombinant variants like LF.7 and LP.8.1.2. The Union Health Ministry has urged the public to continue observing Covid-appropriate behaviour, avoid crowded places, and take necessary health precautions, especially when unwell. The ministry emphasized that while Covid-19 has transitioned into an endemic stage, all circulating variants over the past three years have remained within the Omicron lineage. To ensure preparedness, the government has directed states and union territories to review medical readiness across healthcare facilities, including the availability of oxygen supplies, isolation beds, ventilators, and critical medicines. A nationwide mock drill was conducted to assess oxygen supply infrastructure in hospitals. Surveillance units at the state and district level are closely monitoring Influenza-Like Illness (ILI) and Severe Acute Respiratory Illness (SARI) cases. All SARI admissions and 5% of ILI cases continue to be tested for Covid-19, with positive SARI samples sent for whole genome sequencing to track emerging variants. Meanwhile, 1,219 people recovered from Covid-19 in the last 24 hours, bringing the total number of recoveries this year to 17,164, ministry data showed.

Sickle Cell patients growing in tribal pockets of undivided Visakhapatnam district, says expert
Sickle Cell patients growing in tribal pockets of undivided Visakhapatnam district, says expert

The Hindu

time2 hours ago

  • The Hindu

Sickle Cell patients growing in tribal pockets of undivided Visakhapatnam district, says expert

Sickle Cell Disease is prevalent among the tribal people, particularly those living in the Agency areas of Alluri Sitharama Raju district, according to Paripandla Sridevi, an Associate Professor in the Central Tribal University, Vizianagaram. An estimated 1% of the total population has SCD, and 4% are carriers of the sickle cell trait, Prof. Sridevi said on the eve of World Sickle Cell Day, which is observed on June 19 every year. Prof. Sridevi has been conducting research in the tribal areas of the undivided Visakhapatnam district in the North Andhra region, for the past three years. The research is being conducted as part of the ICMR–National Task Force Project, which has been going on for the past seven years. The SCD is caused by sickle cell gene, a defective one which looks like a sickle. People affected with the disease are born with two sickle cell genes—one from each parent. Those born with one sickle cell gene, called sickle cell trait, are generally healthy, but they can pass on the defective gene to their children, she said. 'Initially, Prof. Sudhakar of the Department of Human Genetics, Andhra University, has worked on the project. Then I worked on the same project in Madhya Pradesh. I have been working on the project for the past three years at Gannela, Madagada and Paderu of ASR district,' Prof. Sridevi told The Hindu. 'I have noticed that SCD patients are unable to get blood transfusions and hydroxyurea on time due to poor amenities in the tribal areas. Stigma is attached to the disease as many tribal people think it is a curse. Some others dismiss it as common anaemia. We train ASHA workers to create awareness among the tribals on the need to opt for timely treatment for SCD and to dispel the myths,' she said. Prof. Sridevi said such research projects act as a bridge between the tribal people and the government as they bring the issues to the notice of the authorities concerned. 'We want the treatment facilities of SCD to be improved. We counsel tribal people about the dangers associated with marriages between close relations, a common practice in the Agency areas,' she said. Quoting from data provided by ASR district DM&HO Dr. Jamal Basha, Prof. Sridevi said that 4,10,380 have been screened for sickle cell anaemia in the undivided Visakhapatnam district as on June 18. Among them, 1,488 were identified as SCD positive, 12,599 carriers and 3,80,665 were negative. The government has made arrangements for the necessary medicines and nutrition for the patients with the goal completely eradicating SCD in Andhra Pradesh by 2047.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store